Frontiers in Oncology | Gastrointestinal Cancers: Gastric and Esophageal Cancers

Original Research

Accepted on 20 Mar 2025

Protocatechualdehyde induced tumor suppressive autophagy through AMPK/ULK1 signaling pathway in gastric cancer

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Mingming Ren
Fangqi Ma
Mengmeng Qin
Xiaoyu Sun
Yi Wang
Xiaohong Zhu
Yan Xu
Nida Cao
Ruohan Zhao
Yunchao Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1563006

Original Research

Published on 20 Mar 2025

A prognostic model based on autophagy-and senescence-related genes for gastric cancer: implications for immunotherapy and personalized treatment

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Shuming Chen
Xiaoxi Han
Yangyang Lu
Shasha Wang
Yuanyuan Fang
Chuanyu Leng
Xueying Sun
Xin Li
Wensheng Qiu
Weiwei Qi

Frontiers in Oncology

doi 10.3389/fonc.2025.1509771

201 views

Original Research

Published on 20 Mar 2025

Establishment and validation of a prognostic nomogram for extra-gastrointestinal stromal tumors

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Guohua Jia
Xiangpan Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1527237

117 views

Case Report

Accepted on 19 Mar 2025

Castleman disease of stomach treated by endoscopic submucosal dissection: A case

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Tingting Sun
Fu-Guo Liu
Xueguo Sun
Ti-Dong Shan
Yan-Yan Lu
Qian Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1563545

Original Research

Published on 18 Mar 2025

Analysis of the safety and efficacy of laparoscopic gastrojejunostomy following neoadjuvant chemotherapy for gastric pyloric obstruction

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Bo Hu
Yishan Zeng

Frontiers in Oncology

doi 10.3389/fonc.2025.1430761

166 views

Original Research

Accepted on 17 Mar 2025

Safety assessment of ripretinib: a real-world adverse event analysis from the Food and Drug Administration adverse event reporting system

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Jiwei Cao
Sentai Wang
Hewen Chen
Yuying Zhou
Jianfeng Chen

Frontiers in Oncology

doi 10.3389/fonc.2025.1542315

Original Research

Published on 17 Mar 2025

Multi-cohort validation based on a novel prognostic signature of anoikis for predicting prognosis and immunotherapy response of esophageal squamous cell carcinoma

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Zhongquan Yi
Xia Li
Yangyang Li
Rui Wang
Weisong Zhang
Hao Wang
Yanan Ji
Jing Zhao
JianXiang Song

Frontiers in Oncology

doi 10.3389/fonc.2025.1530035

254 views

Original Research

Accepted on 13 Mar 2025

Risk Prediction Model for Precancerous Gastric Lesions Based on Magnifying Endoscopy Combined with Narrow-band Imaging Features

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Jingna Tao
Zhongmian Zhang
Linghan Meng
Liju Zhang
Jiaqi Wang
Zhihong Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1554523

Original Research

Accepted on 13 Mar 2025

Construction of a Modified TNM Staging System and Prediction Model Based on Examined Lymph Node Counts for Gastric Cancer Patients at Pathological Stage N3

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Hongyu Zhang
Nan Sun
Feng Li
Qiyang Wang
Zhao Sun
Yawei Zhang
Lei Wang
Chunlin Zhao
Yang Fu

Frontiers in Oncology

doi 10.3389/fonc.2025.1569736

Case Report

Accepted on 13 Mar 2025

Case Report: Esophageal Cancer Under Comprehensive Treatment Strategy-Application and Clinical Outcome Analysis of Combined Immunotherapy, Targeted Therapy, and Low-Dose Radiotherapy

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Yanling Yuan
Xingxi Pan
Lihua Tong
Wanming He
Wen Yang

Frontiers in Oncology

doi 10.3389/fonc.2025.1510371

Original Research

Published on 13 Mar 2025

Prognostic factors in locally advanced oesophageal squamous cell carcinoma: a clinical and radiomic analysis of neoadjuvant immunochemotherapy before surgery

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Yan Zhu
Zhenzhong Zhang
Shuangqing Chen
Genji Bai
Qingqing Xu
Lili Zhang
Max Gao
Aichao Ruan
Lili Guo

Frontiers in Oncology

doi 10.3389/fonc.2025.1508477

195 views

Original Research

Published on 12 Mar 2025

Trends in gastric cancer burden in the Western Pacific region from 1990 to 2021 and projections to 2040

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Tao Zhang
Yiqun Zhang
Xiaofei Leng

Frontiers in Oncology

doi 10.3389/fonc.2025.1506479

269 views

Case Report

Accepted on 11 Mar 2025

Calcifying fibrous tumor of stomach: a rare case report of an upper gastrointestinal bleeding

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Ye Bao Long
Zhong Cailiang

Frontiers in Oncology

doi 10.3389/fonc.2025.1512964

Original Research

Accepted on 11 Mar 2025

DKK3 and SERPINB5 as Novel Serum Biomarkers for Gastric Cancer: Facilitating the Development of Risk Prediction Models for Gastric Cancer

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Yan-Yu Liu
Yan-Fang Fu
Wan-Yu Yang
Zheng Li
Qian Lu
Xin Su
Jin Shi
Si-Qi Wu
Di Liang
Yu-Tong He

Frontiers in Oncology

doi 10.3389/fonc.2025.1536491

Original Research

Published on 11 Mar 2025

Fruquintinib inhibits the migration and invasion of colorectal cancer cells by modulating epithelial-mesenchymal transition via TGF-β/Smad signaling pathway

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Qinqin Song
Hongjiao Wu
Ye Jin
Junzhi Hou
Jiawei Liu
Xuemei Zhang
Wanning Hu
Guogui Sun
Zhi Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1503133

261 views

Case Report

Accepted on 07 Mar 2025

Tocilizumab improves the efficacy of anti-PD-1 in a patient with advanced gastroesophageal junction cancer: a case report

in Gastrointestinal Cancers: Gastric and Esophageal Cancers

Yushi Cai
Xuan Jin
Yun Dai

Frontiers in Oncology

doi 10.3389/fonc.2025.1530387

Navigation group

Articles

Protocatechualdehyde induced tumor suppressive autophagy through AMPK/ULK1 signaling pathway in gastric cancer

A prognostic model based on autophagy-and senescence-related genes for gastric cancer: implications for immunotherapy and personalized treatment

Establishment and validation of a prognostic nomogram for extra-gastrointestinal stromal tumors

Castleman disease of stomach treated by endoscopic submucosal dissection: A case

Analysis of the safety and efficacy of laparoscopic gastrojejunostomy following neoadjuvant chemotherapy for gastric pyloric obstruction

Safety assessment of ripretinib: a real-world adverse event analysis from the Food and Drug Administration adverse event reporting system

Multi-cohort validation based on a novel prognostic signature of anoikis for predicting prognosis and immunotherapy response of esophageal squamous cell carcinoma

Risk Prediction Model for Precancerous Gastric Lesions Based on Magnifying Endoscopy Combined with Narrow-band Imaging Features

Construction of a Modified TNM Staging System and Prediction Model Based on Examined Lymph Node Counts for Gastric Cancer Patients at Pathological Stage N3

Case Report: Esophageal Cancer Under Comprehensive Treatment Strategy-Application and Clinical Outcome Analysis of Combined Immunotherapy, Targeted Therapy, and Low-Dose Radiotherapy

Prognostic factors in locally advanced oesophageal squamous cell carcinoma: a clinical and radiomic analysis of neoadjuvant immunochemotherapy before surgery

Trends in gastric cancer burden in the Western Pacific region from 1990 to 2021 and projections to 2040

Calcifying fibrous tumor of stomach: a rare case report of an upper gastrointestinal bleeding

DKK3 and SERPINB5 as Novel Serum Biomarkers for Gastric Cancer: Facilitating the Development of Risk Prediction Models for Gastric Cancer

Fruquintinib inhibits the migration and invasion of colorectal cancer cells by modulating epithelial-mesenchymal transition via TGF-β/Smad signaling pathway

Tocilizumab improves the efficacy of anti-PD-1 in a patient with advanced gastroesophageal junction cancer: a case report